A multicentric study to compare the immunogenicity, safety and reactogenicity of GSK Biologicals' DTPa-IPV vaccine vs co-administration of GSK's DTPa vaccine and Sanofi-Pasteurs' IPV vaccine at different injection sites, to healthy children.
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2018
At a glance
- Drugs DTaP poliovirus vaccine (Primary) ; DTaP vaccine; Poliovirus vaccine inactivated
- Indications Diphtheria; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline
- 10 Sep 2008 Actual patient number changed from 450 to 452 as reported by ClinicalTrials.gov.
- 31 Jul 2008 The actual completion date for this trial is now 1 Jan 2007.
- 31 Jul 2008 Status changed from in progress to completed according to clinicaltrials.gov record.